BioGaia AB

BioGaia AB Series B
Stock Exchange OTC Publication Venue
EPS
SEK11.94
Market Cap
SEK7.05 B
Shares Outstanding
16.6 M
Public Float
14.07 M

Profile

Address
Kungsbroplan 3
Stockholm AB 112 27
Sweden
Employees -
Website http://www.biogaia.com
Updated 07/08/2019
BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment is comprised of sales of drops, oral rehydration solutions (ORS), digestive health tablets and also cultures as an ingredient in a licensee's products, as well as royalties pertaining to pediatric products.

Financials

View All

Peter Rothschild
Chairman
Isabelle Valerie G. Ducellier
Director